Clinical trial
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
NCT00249990 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00249990 |
|---|---|
| Title | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) |
| Official title | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium |
| Lead sponsor | University of New Mexico, Other |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Corpus Uteri, Endometrial Cancer |
| Intervention type | Drug |
| Interventions | 9-NC in aerosol reservoir |
| Enrollment | 39 |
| Start date | Apr 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Nov 7, 2005 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: